Sherry Heldens
14 works · 5,524 citations · h-index 9
Top works
- Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib
- Non-canonical inflammasome activation targets caspase-11
- Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family
- Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR
- The Secreted Protein Discovery Initiative (SPDI), a Large-Scale Effort to Identify Novel Human Secreted and Transmembrane Proteins: A Bioinformatics Assessment
- Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypes
- ERK Inhibition Overcomes Acquired Resistance to MEK Inhibitors
- Conditional activation of Pik3caH1047R in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutations
- Increased Targeting of Donor Switch Region and IgE in Sγ1-Deficient B Cells
- Data from ERK Inhibition Overcomes Acquired Resistance to MEK Inhibitors
- Data from ERK Inhibition Overcomes Acquired Resistance to MEK Inhibitors
- Supplementary Figures 1-7, Methods from ERK Inhibition Overcomes Acquired Resistance to MEK Inhibitors
- Supplementary Figures 1-7, Methods from ERK Inhibition Overcomes Acquired Resistance to MEK Inhibitors
- Genomic variant calling: Flexible tools and a diagnostic data set